Funding for this research was provided by:
JPIAMR (2018-06335)
Article History
Received: 6 September 2019
Accepted: 16 November 2019
First Online: 28 November 2019
Compliance with ethical standards
:
: IML received from MSD, Gilead for lectures and Aguettant for consulting. ML received fees from 3M, Aspen, Edwards, MSD, Octopharma, Orion, Pfizer for lectures and Aguettant, Amomed for consulting. SE have no conflicts of interest.
Free to read: This content has been made available to all.